🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Santhera Pharmaceuticals Holding AG (0QN1)

London
Currency in CHF
Disclaimer
8.33
+7.69(+1,192.25%)
Closed
0QN1 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
8.338.43
52 wk Range
8.2511.34
Prev. Close
0.64
Open
8.43
Day's Range
8.33-8.43
52 wk Range
8.25-11.34
Volume
13
Average Volume (3m)
271
1-Year Change
-95.62%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
0QN1 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
34.50
Upside
+311.20%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

People Also Watch

429.00
YPSN
-0.12%
3.900
WIHN
0.00%
0.07
SPEXN
5.56%
140.60
KOMN
+1.01%
12.340
KURN
+0.82%

Santhera Pharmaceuticals Holding AG Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.

Employees
46
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.